Palisade Capital Management

ElMindA Ltd. focuses on developing diagnostic and treatment tools for brain-related disorders through its innovative Brain Network Activation (BNA) technology. This platform integrates electroencephalography and event-related potential testing with machine learning and advanced algorithms to visualize and assess the brain's neural networks. By capturing electrophysiological patterns related to specific cognitive tasks, ElMindA creates high-resolution, three-dimensional representations of functional neural pathways, which can inform the understanding of various brain functions, including sensory processing, attention, and memory. The technology has applications in conditions such as mild traumatic brain injury, major depressive disorder, Parkinson's disease, and ADHD, aiming to enhance clinical practices in neuroscience. Founded in 2006, ElMindA operates from Herzliya, Israel, with an additional office in Glenview, Illinois.

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®.

Neurologix, Inc. is a clinical-stage biotechnology company focused on the discovery and development of gene therapy treatments for serious disorders of the brain and central nervous system. The company aims to provide alternatives to traditional surgical and pharmacological interventions. Its primary areas of research include therapies for Parkinson's disease and epilepsy, conditions that significantly impact patients' quality of life. Additionally, Neurologix is involved in developing gene transfer therapies for other neurodegenerative and metabolic disorders, such as Huntington's disease, depression, and genetically-based obesity. Founded in 1999, Neurologix is headquartered in Fort Lee, New Jersey.

Send Word Now is the worldwide provider of enterprise communications services. Their easy-to-use, web-based and mobile solutions are deployed by businesses, government agencies, universities and non-profit organizations to ensure fast, effective communication when it is needed the most. Send Word Now was founded in 2001, by a group of individuals who recognized the need for immediate, reliable and multimodal crisis communications after the tragedies of September 11, 2001. Since that time, organizations across the globe have faced a multitude of natural and man-made disruptions, creating a heightened focus on business continuity, regulatory compliance, security and the ability to audit information flow. Further, today’s borderless business environment and increasingly mobile workforce have surfaced new needs for operations-focused communication and collaboration. Send Word Now is successfully transforming the way organizations communicate globally, both for emergency situations, and for every day, time-sensitive interactions. Their enterprise-class emergency notification system is capable of transmitting tens of thousands of voice and text messages in minutes, while providing a full audit trail for after action reporting and follow-up. Their mobile conferencing, collaboration and workflow solutions keep employees informed and connected to the people and information they need. And, everything is backed by their 100% Uptime reliability guarantee, and unmatched 24x7x365 customer support. In emergencies, or every day. When rapid, effective communication is essential for success, rely on Send Word Now for innovative, secure and reliable notification and collaboration solutions.

Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

Shoe Sensation, Inc. operates a regional chain of family-oriented shoe stores across several states, including Arkansas, Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Tennessee, and West Virginia. Founded in 1974 and based in Jeffersonville, Indiana, the company specializes in providing a diverse selection of quality name-brand footwear for men, women, and children. Their inventory includes various types of shoes, such as running shoes, walking shoes, safety toe boots, heels, and sneakers, catering to the footwear needs of customers from toddlers to senior citizens. Shoe Sensation aims to offer a better-branded merchandise mix, ensuring a wide range of options for the entire family.

Ikonisys, Inc. is a medical diagnostic company focused on the design, manufacture, and marketing of advanced diagnostic products for cancer detection and genetic disorder screening. Headquartered in New Haven, Connecticut, Ikonisys offers a range of innovative tools, including the Ikoniscope Robotic Microscope, which automates slide handling and image analysis, reducing human error in testing. Their product line features various oncoFISH applications, such as those for bladder cancer and HER2 status in breast tissue, as well as tools for detecting genetic abnormalities in prostate tissue biopsies. The company is committed to transforming diagnostic medicine by enabling early and accurate disease detection through a combination of cutting-edge technology and scientific research, ultimately assisting healthcare professionals in providing optimal patient care. Founded in 1999, Ikonisys continues to advance its capabilities in non-invasive diagnostic solutions.

Language Weaver, Inc. specializes in developing and licensing automated translation solutions tailored for multinational corporations, government entities, and translation service providers. The company offers a range of products, including the LW Enterprise Translation Server, which facilitates on-site language translation within enterprises, and the LW Custom Enterprise Translation Server, designed for specific domains such as information technology, automotive, medical, and finance. Additionally, Language Weaver provides LW Translation On Demand, an on-demand translation service, along with LW Custom Translation On Demand, hosted on dedicated servers. The company also offers LW Professional Services, which encompass software training, the development of custom language pairs, and the preparation of parallel data.

Achieve3000, Inc. is a cloud-based literacy platform that provides differentiated literacy solutions aimed at enhancing reading comprehension, fluency, vocabulary, and writing proficiency for students in grades 2 through 12. Founded in 2000 and based in Red Bank, New Jersey, the company offers a range of educational programs, including KidBiz3000 for younger students, TeenBiz3000 for middle and high school learners, and Spark3000 for adult education. Achieve3000's proprietary software customizes content delivery based on individual reading levels, ensuring that each student engages with material suited to their abilities. The platform serves various educational institutions, including schools and school districts, and is designed to align with state curricula while supporting remote and on-site instruction.

Versura is an online business-to-business exchange focused on enhancing opportunities within the higher education finance sector. The platform provides educational institutions with an Internet-based service that simplifies the process of selecting preferred lenders, allowing schools to customize loan programs to ensure optimal value for both their institutions and students. For lenders and financial institutions, Versura serves as an open digital marketplace that broadens market access, enabling them to connect with colleges and universities nationwide. Additionally, loan sellers can engage with buyers interested in acquiring all or part of their loan portfolios, facilitating a more efficient and expansive financial ecosystem in higher education.